Ticker Details
Nautilus Biotechnology, Inc.
IPO Date:	August 7, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$121.47M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.12 | 4.08%
Avg Daily Range (30 D):	$0.07 | 4.90%
Avg Daily Range (90 D):	$0.11 | 4.87%

Institutional Daily Volume
Avg Daily Volume:	.23M
Avg Daily Volume (30 D):	.71M
Avg Daily Volume (90 D):	.58M

Trade Size
Avg Trade Size (Sh.):	142
Avg Trade Size (Sh.) (30 D):	159
Avg Trade Size (Sh.) (90 D):	136

Institutional Trades
Total Institutional Trades:	37
Avg Institutional Trade:	$1.71M
Avg Institutional Trade (30 D):	$.54M
Avg Institutional Trade (90 D):	$5.23M
Avg Institutional Trade Volume:	.56M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.39M
Avg Closing Trade (30 D):	$9.93M
Avg Closing Trade (90 D):	$9.93M
Avg Closing Volume:	870.51K

News

May 3, 2024 @ 4:00 PM Nautilus Biotechnology (NAUT) Upgraded to Buy: Her... Source: Zacks Equity Research

Apr 30, 2024 @ 12:00 PM Nautilus Biotechnology Reports First Quarter 2024 ... Source: Nautilus Biotechnology Inc.

Feb 22, 2024 @ 1:00 PM Nautilus Biotechnology to Participate in the TD Co... Source: Nautilus Biotechnology Inc.

Nov 1, 2023 @ 12:05 PM Nautilus Biotechnology Appoints Martin Huber, Ph.D... Source: Nautilus Biotechnology Inc.

Oct 31, 2023 @ 12:05 PM Nautilus Biotechnology Reports Third Quarter 2023 ... Source: Nautilus Biotechnology Inc.

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.45	$-.11	$-.12
Diluted EPS	$-.45	$-.11	$-.12
Revenue		$.19M	$M
Gross Profit		$.18M	$M
Net Income / Loss	$-56.52M	$-14.47M	$-14.7M
Operating Income / Loss		$-15.75M	$-16.12M
Cost of Revenue		$.02M	$M
Net Cash Flow	$-21.29M	$-1.46M	$2.24M
PE Ratio